Abstract | BACKGROUND: METHODS: A prospective study was conducted at Institute of Kidney Disease and Research Centre, Ahmedabad from January 2014 to December 2016. Antenatal women (108) with iron deficiency anaemia were the study subjects. Socio-demographic profile was recorded and anaemia was assessed based on recent haemoglobin reports. Iron deficiency was diagnosed on basis of serum ferritin value. Intravenous ferric carboxymaltose as per total correction dose (maximum 1500mg) was administered to all women; the improvement in haemoglobin levels were assessed after 3 weeks of total dose infusion. RESULTS: Most of the women(n= 45, 41.7%), were in the age group of 27-30 years. Most of the women (n = 64, 59.3%) had moderate anaemia as per WHO guidelines. Mean haemoglobin levels significantly increased over a period of 3 weeks after Ferric carboxymaltose administrationand no serious life threatening adverse events were observed. CONCLUSIONS:
|
Authors | Vineet Mishra, Khusaili Gandhi, Priyankur Roy, Shaheen Hokabaj, Kunur N Shah |
Journal | Journal of Nepal Health Research Council
(J Nepal Health Res Counc)
Vol. 15
Issue 2
Pg. 96-99
(Sep 08 2017)
ISSN: 1999-6217 [Electronic] Nepal |
PMID | 29016575
(Publication Type: Journal Article, Observational Study)
|
Chemical References |
- Ferric Compounds
- Hematinics
- Hemoglobins
- ferric carboxymaltose
- Maltose
- Ferritins
|
Topics |
- Adult
- Anemia, Iron-Deficiency
(drug therapy)
- Female
- Ferric Compounds
(administration & dosage, adverse effects, therapeutic use)
- Ferritins
(blood)
- Hematinics
(administration & dosage, adverse effects, therapeutic use)
- Hemoglobins
- Humans
- Injections, Intravenous
- Maltose
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Nepal
- Pregnancy
- Pregnancy Complications, Hematologic
(drug therapy)
- Prospective Studies
- Socioeconomic Factors
- Young Adult
|